Proscia and Ibex Medical Analytics Partner to Improve Prostate Cancer Diagnosis With AI-Powered Workflows

By Author Proscia | March 12, 2021

Proscia, a leading provider of digital and computational pathology solutions, and Ibex Medical Analytics, the pioneer in artificial intelligence (AI)-based cancer diagnostics, have entered into a strategic partnership to support pathologists in detecting prostate cancer, the second leading cause of cancer death among men in the United States. Through the collaboration, the partners will advance the use of computationally-enabled workflows leveraging AI, which drive accuracy, efficiency, and quality gains in routine pathology diagnosis.

New to digital pathology? Learn how whole slide imaging is changing the industry here.

Our website uses cookies. By using this site, you agree to its use of cookies.